Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
14 participants
INTERVENTIONAL
2024-02-05
2024-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Caffeinated Chewing Gum & Wrestling Performance
NCT06758336
Caffeine & Bodybuilding Dehydration Ability
NCT06431035
Caffeinated Chewing Gum on 400-meter Performance
NCT06430996
Carbohydrate Rinsing and Caffeine Gum on Performance of Romanian Deadlifts Performance
NCT05900349
Effects of Energy Drink on Repeated Sprint Performance and Cognitive Function in Athletes
NCT07104188
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
caffeine gum
15 minutes before exercise
caffeinate chewing gum
participants either chewed caffeinated gum (CAF) containing 3 mg/kg caffeine or a caffeine-free placebo gum (PLA) for 10 minutes prior to undertaking a series of tests on-ice and off-ice.
placebo
15 minutes before exercise
caffeinate chewing gum
participants either chewed caffeinated gum (CAF) containing 3 mg/kg caffeine or a caffeine-free placebo gum (PLA) for 10 minutes prior to undertaking a series of tests on-ice and off-ice.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
caffeinate chewing gum
participants either chewed caffeinated gum (CAF) containing 3 mg/kg caffeine or a caffeine-free placebo gum (PLA) for 10 minutes prior to undertaking a series of tests on-ice and off-ice.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 2\. 6 months of continuous training,
* 3\. 3 months of recovery from sports injuries such as strains and sprains
Exclusion Criteria
* 2\. has not trained regularly for the past 6 months.
* 3\. has recovered from an athletic injury.
* 4\. have been recovering from a sports injury for less than 3 months, or have epilepsy, hypertension, hyperlipidemia, heart disease, arthritis, osteoporosis, brain injury, or a history of caffeine allergy.
20 Years
40 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan Sport University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chih-Hui Chiu
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ChihHui Chiu, PhD
Role: STUDY_DIRECTOR
National Taiwan University of Sport
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Taiwan University of Sport
Taichung, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
113-4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.